Immunovant, INC. (IMVT) — DEF 14A Filings
All DEF 14A filings from Immunovant, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Immunovant Sets August 27 Virtual Annual Meeting, Details Equity Awards
— Jul 9, 2025 Risk: low
Immunovant, Inc. filed a DEF 14A on July 9, 2025, for its Annual Meeting of Stockholders scheduled for August 27, 2025, indicating a focus on corporate governan -
Immunovant Files Definitive Proxy Statement for August Meeting
— Jun 26, 2024 Risk: low
Immunovant, Inc. filed its definitive proxy statement on June 26, 2024, for its annual meeting on August 12, 2024. The company, formerly known as Health Science
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX